Literature DB >> 29661771

Antimalarial Drugs for the Prevention of Chronic Kidney Disease in Patients with Rheumatoid Arthritis: The Importance of Controlling Chronic Inflammation?

Jennifer C Rodrigues1, Joanne M Bargman2.   

Abstract

Entities:  

Keywords:  Antimalarials; Arthritis; B-lymphocytes; Cell Differentiation; Chronic; Chronic inflammation; Dendritic Cells; Fibroblasts; Gastrointestinal Microbiome; Homeostasis; Humans; Hydroxychloroquine; Renal Insufficiency; Rheumatoid; Rheumatoid Arthritis; Rheumatoid Factor; Smoking; Synovial Membrane; Th17 Cells; chronic kidney disease; cytokines

Mesh：

Substances：

Year:  2018        PMID： 29661771      PMCID： PMC5969469          DOI： 10.2215/CJN.03300318

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  15 in total

Review 1.  Secondary minimal change disease.

Authors:  Richard J Glassock
Journal:  Nephrol Dial Transplant       Date:  2003-08       Impact factor: 5.992

Review 2.  The role of antimalarial agents in the treatment of SLE and lupus nephritis.

Authors:  Senq-J Lee; Earl Silverman; Joanne M Bargman
Journal:  Nat Rev Nephrol       Date:  2011-10-18       Impact factor: 28.314

Review 3.  One year in review 2017: pathogenesis of rheumatoid arthritis.

Authors:  Francesca Angelotti; Alice Parma; Giacomo Cafaro; Riccardo Capecchi; Alessia Alunno; Ilaria Puxeddu
Journal:  Clin Exp Rheumatol       Date:  2017-06-07       Impact factor: 4.473

Review 4.  Drug-induced nephrotoxicity in inflammatory bowel disease.

Authors:  Konstantinos A Oikonomou; Andreas N Kapsoritakis; Ioannis Stefanidis; Spyros P Potamianos
Journal:  Nephron Clin Pract       Date:  2011-06-15

5.  Discrepancy between Medical Evidence Form 2728 and renal biopsy for glomerular diseases.

Authors:  J Bradley Layton; Susan L Hogan; Caroline E Jennette; Barbara Kenderes; Jenna Krisher; J Charles Jennette; William M McClellan
Journal:  Clin J Am Soc Nephrol       Date:  2010-08-05       Impact factor: 8.237

Review 6.  5-Aminosalicylates and renal function in inflammatory bowel disease: a systematic review.

Authors:  Javier P Gisbert; Yago González-Lama; José Maté
Journal:  Inflamm Bowel Dis       Date:  2007-05       Impact factor: 5.325

7.  End-stage renal disease in patients with rheumatoid arthritis.

Authors:  Sunita Paudyal; Frances M Yang; Christopher Rice; Chen-Chun Chen; Michael Skelton; Monique Bethel; Shilpa Brown; Norris Stanley Nahman; Laura Carbone
Journal:  Semin Arthritis Rheum       Date:  2016-08-02       Impact factor: 5.532

8.  Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus.

Authors:  Mary J Roman; Beth-Ann Shanker; Adrienne Davis; Michael D Lockshin; Lisa Sammaritano; Ronit Simantov; Mary K Crow; Joseph E Schwartz; Stephen A Paget; Richard B Devereux; Jane E Salmon
Journal:  N Engl J Med       Date:  2003-12-18       Impact factor: 91.245

Review 9.  Metabolic and cardiovascular benefits of hydroxychloroquine in patients with rheumatoid arthritis: a systematic review and meta-analysis.

Authors:  Claire Rempenault; Bernard Combe; Thomas Barnetche; Cécile Gaujoux-Viala; Cédric Lukas; Jacques Morel; Charlotte Hua
Journal:  Ann Rheum Dis       Date:  2017-09-25       Impact factor: 19.103

Review 10.  2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis.

Authors:  Jasvinder A Singh; Kenneth G Saag; S Louis Bridges; Elie A Akl; Raveendhara R Bannuru; Matthew C Sullivan; Elizaveta Vaysbrot; Christine McNaughton; Mikala Osani; Robert H Shmerling; Jeffrey R Curtis; Daniel E Furst; Deborah Parks; Arthur Kavanaugh; James O'Dell; Charles King; Amye Leong; Eric L Matteson; John T Schousboe; Barbara Drevlow; Seth Ginsberg; James Grober; E William St Clair; Elizabeth Tindall; Amy S Miller; Timothy McAlindon
Journal:  Arthritis Rheumatol       Date:  2015-11-06       Impact factor: 10.995
View more
  2 in total

1.  Effects of hydroxychloroquine on proteinuria in membranous nephropathy.

Authors:  Yan-Jiao Cheng; Xu-Yang Cheng; Yi-Miao Zhang; Fang Wang; Xin Wang; Li-Qiang Meng; Gang Liu; Zhao Cui; Ming-Hui Zhao
Journal:  J Nephrol       Date:  2021-11-30       Impact factor: 3.902

2.  Characterization of the Effect of Renal Impairment on Upadacitinib Pharmacokinetics.

Authors:  Mohamed-Eslam F Mohamed; Sheryl Trueman; Tian Feng; Jaclyn Anderson; Thomas C Marbury; Ahmed A Othman
Journal:  J Clin Pharmacol       Date:  2019-01-11       Impact factor: 3.126
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.